Archive

Deprescribing to optimise drug therapy

Written by Christine Clark | 27 Apr 2023

Debi Bhattacharya is Professor of Behavioural Medicine at the University of Leicester, UK. As a former primary care pharmacist, she has experience of both practice and research into… read more.

CHARMER – a different kind of deprescribing intervention study

Written by Christine Clark | 26 Apr 2023

The CHARMER study of a proactive deprescribing intervention is different from previous studies and addresses five critical factors identified by prescribers and patients as being key to success,… read more.

New study provides first published examples of medication deprescribing protocols for type 2 diabetes

Written by Charlie King | 25 Apr 2023

A qualitative case series research study sponsored by the American College of Lifestyle Medicine and published in Clinical Diabetes provides the first published examples of protocols to help guide clinical decision making on… read more.

Barriers and enablers for deprescribing

Written by Christine Clark | 25 Apr 2023

There is no ‘one-size-fits-all’ deprescribing intervention and a good understanding of the barriers and enablers to effective deprescribing is needed, according to Debi Bhattacharya, Professor of Behavioural Medicine… read more.

Deprescribing – reactive and proactive

Written by Christine Clark | 24 Apr 2023

Debi Bhattacharya is Professor of Behavioural Medicine at the University of Leicester, UK. As a former primary care pharmacist, she has experience of both practice and research into… read more.

Pharmacist-based deprescribing successfully reduced older adults’ exposure to anticholinergic drugs

Written by Charlie King | 22 Jul 2022

Anticholinergics, a class of drugs frequently prescribed for depression, urinary incontinence and many other conditions common in older adults, affect the brain by blocking acetylcholine, a nervous system… read more.

« Previous 1 2